Posts Tagged ‘medical patent news’
Medical Patent News of the Week
As a medical device patent attorney, I take a special interest in news and commentary relating to medical patents, dental patents, and related technology. In this regard, below is a recap of medical patent news for the week: Five Medical Patent Applications for Lymphoma MMRGlobal filed five patent applications to treat lymphoma. They include protection for anti-CD20 antibodies, methods ... Read More
Medicine, drugs, genes and the death of a patent niche?
Inventors pursuing medical patents involving genes should listen to this… On October 29th, the federal government reversed a longstanding policy by saying that human genes are part of nature and therefore cannot be patented. While the U.S. Patent and Trademark Office is not changing its rules for the time being, this decision may reverse the nearly 30 year old legal precedent of patenting pa... Read More
Patent Pending Drug for Artherosclerosis
Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). Merck’s second generation niacin receptor agonist is a combatant to artherosclerosis. Will the patented drug enter the market? ... Read More
Patent Approved for Hythiam’s Alcohol Treatment Program
Interest in the mind-body connection in particular is a trend that has continued to grow over the last several years, and you can see this in patented products in virtually every category, including fitness, publishing, alternative health practices, the expansion of nutraceuticals into even our soda, etc.
No Patenting Required for Pharmaceutical Breakthrough Drugs?
If you want to widen the landscape to give the little guys a chance, I'm all for it. But, give them their full due in the fruits of patent protection through which they can compete from a position of strength through proprietary control.
